US Markets: S&P 500 and Nasdaq Slump as Tech Giants Face Pressure

Wall Street witnessed a mixed session on Monday as the S&P 500 and Nasdaq Composite retreated, heavily weighed down by a sell-off in megacap technology stocks. While the Dow Jones Industrial Average managed to find gains, investors remained cautious amid shifting geopolitical tensions and evolving expectations regarding Federal Reserve policy.

Tech Sell-off Drags Down Major Indices

The Nasdaq Composite bore the brunt of the market volatility, falling 339.67 points or 1.28% to close at 26,178.26. This decline was largely driven by a sharp downturn in Alphabet, alongside losses in other tech titans such as Meta, Amazon, and Microsoft. The sector, which has recently been propelled by artificial intelligence optimism, is now facing scrutiny over the massive infrastructure spending required by hyperscalers.

SpaceX also played a significant role in the Nasdaq's decline. Despite reporting $100.8 billion in cash and cash equivalents as of June 19, the Elon Musk-led company saw its shares tumble following its first-ever debt offering on Monday. Analysts suggest that while the AI-driven rally is vulnerable to sentiment shifts, the fundamental strength remains in the data center buildout components.

Geopolitics and Energy Markets Find Relief

In contrast to the tech sector's struggle, oil prices saw a decline following positive news regarding U.S.-Iran negotiations. Mediators reported that officials made "great progress" during the first round of talks in Switzerland, agreeing on a roadmap toward a final deal within 60 days.

While tensions persist in regions like Lebanon and the Strait of Hormuz, the potential for a stabilized energy market is acting as a catalyst. Lower energy prices are viewed as a positive development for both consumers and businesses, providing a slight cushion against the broader market volatility.

The Federal Reserve and Inflation Outlook

The Dow Jones Industrial Average provided a silver lining, rising 162.36 points or 0.29% to end at 51,727.06, supported by the healthcare and industrial sectors. Notably, biotech firm Apogee Therapeutics surged following news that AbbVie would acquire it for $10.9 billion in cash.

However, macro-economic concerns loom large. A "hawkish" stance from the Federal Reserve under new Chair Kevin Warsh has pushed U.S. Treasury yields higher, pressuring stock prices. Investors are now hyper-focused on Thursday’s Personal Consumption Expenditures (PCE) data—the Fed's preferred inflation gauge. With markets currently pricing in a 25-basis-point rate hike for September, any stronger-than-expected inflation reading could tighten monetary policy further.

Key Takeaways

  • Tech Volatility: Megacap stocks like Alphabet and Meta led a Nasdaq slump of 1.28%, as investors question the high costs of AI infrastructure expansion.
  • Geopolitical Progress: U.S.-Iran talks in Switzerland have resulted in a 60-day roadmap, leading to a drop in oil prices and providing relief to energy-sensitive sectors.
  • Fed Watch: Markets are bracing for the PCE inflation data this Thursday, which will heavily influence whether the Federal Reserve maintains its hawkish trajectory toward price stability.